Study of Vimseltinib for Tenosynovial Giant Cell Tumor

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

August 10, 2023

Study Completion Date

July 31, 2026

Conditions
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisGiant Cell Tumor of Tendon SheathTenosynovial Giant Cell Tumor, DiffuseTenosynovial Giant Cell Tumor, Localized
Interventions
DRUG

Vimseltinib

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (35)

10016

Memorial Sloan-Kettering Cancer Center, New York

27710

Duke Sarcoma Research, Durham

43210

Ohio State University, Columbus

55902

Mayo Clinic Rochester, Rochester

66160

University of Kansas, Kansas City

77030

University of Texas MD Anderson Cancer Center, Houston

80045

University of Colorado, Aurora

91010

City of Hope, Duarte

95817

UC Davis Comprehensive Cancer Center, Sacramento

98109

Seattle Cancer Care Alliance, Seattle

02215

Dana Farber Cancer Institute, Boston

Unknown

Chris O'Brien Lifehouse, Camperdown

McGill University, Montreal

Princess Margaret Hospital, Toronto

Institut Bergonié, Bordeaux

Centre Léon Bérard, Lyon

Institut Gustave Roussy, Villejuif

Helios Klinikum Berlin-Buch, Berlin

University Hospital Essen (Universitätsklinikum Essen), Essen

Prince of Wales Hospital, Hong Kong

Istituto Ortopedico Rizzoli, Bologna

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale", Naples

Istituto Oncologico Veneto, Padua

Istituto Nazionale Tumori Regina Elena, Rome

Leiden University Medical Center, Leiden

Oslo University Hospital, Oslo

Klinika Nowotworów Tkanek Miękkich, Kości i Czerniaków Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Warsaw

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Fundacion Jimenez Diaz, Madrid

Hospital Clinico San Carlos, Madrid

Universitäts-Kinderspital beider Basel (UKBB), Basel

Cancer & Haematology Centre, The Churchill Hospital - Oxford University Hospitals NHS Foundation Trust, London

University College London Hospitals, London

Sponsors
All Listed Sponsors
lead

Deciphera Pharmaceuticals, LLC

INDUSTRY